arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Alpha Teknova, Inc.

TKNO Health Care Biotechnology: In Vitro & In Vivo Diagnostic Substances
$6.15
▼ -16.8% Today
as of Oct 22, 16:52 ET
Last 30 days -9.82% Sep 14 → Oct 22
$5.57 $6.58 $7.59 $8.60 $9.61 Sep 14 Sep 22 Sep 29 Oct 07 Oct 14 Oct 22
Open
$5.60
High
$6.47
Low
$5.60
Volume
$1M
Avg Vol
$230,301
Mkt Cap
$468M
P/E (TTM)
—
Beta
—
52w High
$9.48
52w Low
$1.91
Div Yield
—
Shares Out
$54M

Recent Press Releases & News last 60 days · 6 items

Oct 21 · 07:45 MT Newswires
Alpha Teknova Prices $40 Million Public Offering of Shares
Oct 20 · 21:47 Investing.com
Alpha Teknova stock tumbles on public offering announcement
Oct 2 · 20:43 MT Newswires
Alpha Teknova, Pluristyx Announce Preparation of PluriFreeze Drug Master File for US FDA Submission
▸ Show all 6 press releases & news Free account →

TKNO earnings at a glance

Alpha Teknova, Inc. (TKNO) is scheduled to report earnings on Thursday, November 5, 2026 — in 13 days. Analysts expect earnings per share of -$0.06, compared with -$0.08 in the same quarter last year (+25%). The options market is pricing a move of about ±26.7% after the report, a range of roughly $4.51 to $7.79 from today's $6.15. Over its last 6 reports the stock rose the next day 4 times and fell 2, moving ±8.9% on average; after the most recent report on Aug 5, 2026 it moved +16.4%. That means options currently expect more movement than TKNO has typically delivered. TKNO beat the consensus EPS estimate in 1 of its last 2 reported quarters. Implied volatility is currently 226%. The share price of $6.15 sits in the middle of its 52-week range.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$1.91
$9.48
56% of range
Avg surprise (last 2)
+12.5%
Avg reaction (last 6)
+7.3%
67% positive
Latest IV / EM
226%
EM ±26.7% · $8 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.34$-0.27$-0.20$-0.13$-0.06 Actual $-0.31Actual $-0.25Actual $-0.34Actual $-0.20Actual $-0.13Actual $-0.15Actual $-0.09Actual $-0.07Actual $-0.08Actual $-0.09Est $-0.09Actual $-0.08Actual $-0.06Est $-0.08 MarJunSepMarJunSepMar/2025Jun/2025Sep/20258KMar/2026Jun/2026
Revenue vs Net Income Revenue Net income
$-8M$-2M$3M$8M$13M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Wed Aug 5, 2026Jun/2026 $-0.06 $-0.08 +25.0% — +16.4% earnings
Wed May 6, 2026Mar/2026 $-0.08 — — +11.1% +9.9% earnings
Thu Feb 26, 20268K 2026-02-26 $-0.09 $-0.09 0.0% — +13.2% earnings
Thu Nov 6, 2025Sep/2025 $-0.08 — — — -2.1% earnings
Thu Aug 7, 2025Jun/2025 $-0.07 — — — -2.5% earnings
Thu May 8, 2025Mar/2025 $-0.09 — — — +9.3% earnings
Mon Sep 30, 2024Sep 2024 $-0.15 — — — — financials
Sun Jun 30, 2024Jun 2024 $-0.13 — — — — financials
Sun Mar 31, 2024Mar 2024 $-0.20 — — — — financials
Sat Sep 30, 2023Sep 2023 $-0.34 — — — — financials
Fri Jun 30, 2023Jun 2023 $-0.25 — — — — financials
Fri Mar 31, 2023Mar 2023 $-0.31 — — — — financials

Upcoming

DateFiscalTimeEPS EstLY EPSYoY %Δ
Thu Nov 5, 2026Sep/2026OTHER -$0.06-$0.08 +25.0%

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$12M$11M—$10M$10M$10M—$10M
Cost of revenue$7M$7M—$7M$6M$7M—$9M
Gross profit$5M$4M—$3M$4M$3M—$90,000
Operating income$-3M$-4M—$-4M$-3M$-5M—$-7M
Net income$-3M$-5M—$-4M$-4M$-5M—$-8M
EPS (diluted)$-0.06$-0.08—$-0.08$-0.07$-0.09—$-0.15

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$6M$4M$6M$3M$3M$3M$4M$6M
Inventory$7M$7M$7M$7M$8M$7M$7M$8M
Total current assets$31M$32M$35M$37M$38M$40M$43M$46M
Total assets$96M$99M$104M$108M$110M$114M$119M$124M
Long-term debt$13M$13M$13M$13M$13M$13M—$11M
Total liabilities$33M$34M$35M$35M$34M$35M$36M$37M
Total equity$63M$65M$69M$73M$76M$79M$82M$87M

Implied volatility — last 90 days

79%162%245%328%411% Jun 09 — IV 268% · EM ±33.6%Jun 10 — IV 284% · EM ±33.6%Jun 11 — IV 329% · EM ±36.4%Jun 12 — IV 361% · EM ±36.9%Jun 17 — IV 411% · EM ±17.2%Jun 19 — IV 173% · EM ±38.2%Jun 22 — IV 153% · EM ±32.0%Jun 23 — IV 185% · EM ±37.8%Jun 24 — IV 130% · EM ±26.0%Jun 26 — IV 145% · EM ±27.8%Jun 29 — IV 125% · EM ±22.1%Jun 30 — IV 141% · EM ±24.2%Jul 01 — IV 189% · EM ±31.5%Jul 02 — IV 158% · EM ±25.5%Jul 03 — IV 163% · EM ±25.5%Jul 06 — IV 199% · EM ±27.6%Jul 07 — IV 188% · EM ±24.9%Jul 08 — IV 176% · EM ±22.1%Jul 09 — IV 133% · EM ±15.7%Jul 10 — IV 186% · EM ±20.5%Jul 13 — IV 232% · EM ±19.4%Jul 15 — IV 304% · EM ±18.0%Jul 16 — IV 383% · EM ±16.0%Jul 20 — IV 122% · EM ±28.8%Jul 21 — IV 155% · EM ±36.0%Jul 22 — IV 192% · EM ±43.9%Jul 23 — IV 188% · EM ±42.3%Jul 29 — IV 201% · EM ±40.3%Jul 30 — IV 196% · EM ±38.4%Jul 31 — IV 204% · EM ±39.0%Aug 03 — IV 202% · EM ±35.8%Aug 04 — IV 208% · EM ±35.8%Aug 05 — IV 154% · EM ±25.8%Aug 06 — IV 327% · EM ±52.8%Aug 07 — IV 267% · EM ±41.8%Aug 10 — IV 258% · EM ±35.7%Aug 11 — IV 204% · EM ±27.0%Aug 12 — IV 130% · EM ±16.2%Aug 13 — IV 96% · EM ±11.4%Aug 14 — IV 180% · EM ±19.9%Aug 17 — IV 158% · EM ±13.2%Aug 18 — IV 294% · EM ±21.3%Aug 19 — IV 270% · EM ±15.9%Aug 24 — IV 108% · EM ±22.5%Aug 25 — IV 100% · EM ±20.4%Aug 26 — IV 119% · EM ±23.9%Aug 27 — IV 98% · EM ±19.2%Aug 28 — IV 128% · EM ±24.6%Aug 31 — IV 126% · EM ±22.3%Sep 01 — IV 152% · EM ±26.1%Sep 02 — IV 125% · EM ±20.9%Sep 11 — IV 236% · EM ±26.1%Sep 14 — IV 327% · EM ±27.3%Sep 15 — IV 351% · EM ±25.4%Sep 21 — IV 83% · EM ±17.4%Sep 22 — IV 85% · EM ±17.4%Sep 23 — IV 157% · EM ±31.4%Sep 24 — IV 80% · EM ±15.6%Sep 25 — IV 85% · EM ±16.3%Sep 28 — IV 104% · EM ±18.5%Sep 29 — IV 118% · EM ±20.4%Sep 30 — IV 168% · EM ±28.1%Oct 01 — IV 129% · EM ±20.9%Oct 02 — IV 128% · EM ±20.0%Oct 06 — IV 277% · EM ±36.6%Oct 07 — IV 220% · EM ±27.6%Oct 08 — IV 226% · EM ±26.7%

Sector peers

MYGN
Myriad Genetics, Inc.
$409M $5.76+4.0%
ACHV
Achieve Life Sciences, Inc.
$745M $6.50-0.1%
IMDX
Insight Molecular Diagnostics Inc.
$114M $2.84-6.3%
QDEL
QuidelOrtho Corporation
$844M $13.48-5.1%
ICCC
ImmuCell Corporation
$87M $10.44-0.1%
QCLS
Q/C Technologies, Inc.
$19M $0.53+6.0%

TKNO earnings FAQ

When is TKNO's next earnings date?

Alpha Teknova, Inc. is expected to report on November 5, 2026.

What is TKNO's expected move for earnings?

Options currently price a move of about ±26.7%, or $1.64 per share either way from $6.15.

How does TKNO stock usually react to earnings?

Across the last 6 reports the average next-day move was ±8.9%, up 4 times and down 2 times.

What EPS are analysts expecting from Alpha Teknova, Inc.?

The consensus estimate is -$0.06 per share, versus -$0.08 a year ago.

What is TKNO's implied volatility?

TKNO's at-the-money implied volatility is about 226% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in